Curos port protection

October 28, 2008

Email this news item to a friend/colleague

Ivera Medical Corporation, a San Diego (CA) based medical device company today announced that it received FDA 510(k) clearance to begin marketing its Curos™ Port Protector, an innovative medical device that decontaminates needleless intravenous (I.V.) access ports, and helps to prevent touch and airborne contamination.

The Curos Port Protector is designed to reduce patient exposure to the risks of hospital acquired bloodstream infections and help maintain hospital infection control protocols.

“The Curos Port Protector market approval is a significant milestone toward the success of our company,” Bob Rogers, Chief Executive Officer of Ivera Medical said. “It confirms our commitment to assist healthcare providers in their efforts to reduce bloodstream infections caused by touch or airborne contamination of needleless I.V. ports.”

Click here for the full press release.

More news at IVTEAM